divislab glp-1 novo nordisk ad war leads to lawsuit by Nordisk, claiming Eli Lilly misleads Novo Nordisk CEO: People have

H., Dalal, M

Bantounou MA, Shoaib K, Mazzoleni A, Modalavalasa H, Kumar N, Philip S

Patients on weekly semaglutide injections have more flexibility for timing adjustments than those on daily oral formulations

Cell Rep 11(4):577591 Kamba T, McDonald DM (2007) Mechanisms of adverse effects of anti-VEGF therapy for cancer

Maintaining proper fluid intake, especially during GLP-1 therapy when gastrointestinal symptoms may affect hydration status, is important for cognitive performance

The NGO-SS-HA-Gef nanocarrier showed significant responsiveness to the high level of GSH in A549 lung cancer cells due to the disulfide linkage